메뉴 건너뛰기




Volumn 110, Issue 2, 2008, Pages 116-122

Clinical heterogeneity in sodium channelopathies: What is the meaning of carrying a genetic mutation?

Author keywords

Brugada syndrome; SCN5A; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

PROTEIN SCN5A; SODIUM CHANNEL;

EID: 43049105050     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110490     Document Type: Article
Times cited : (12)

References (13)
  • 4
  • 5
    • 0037978018 scopus 로고    scopus 로고
    • Genetics and arrhythmias
    • Roberts R, Brugada R: Genetics and arrhythmias. Annu Rev Med 2003;54:257-267.
    • (2003) Annu Rev Med , vol.54 , pp. 257-267
    • Roberts, R.1    Brugada, R.2
  • 10
    • 13444300924 scopus 로고    scopus 로고
    • Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A: Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;1115:659-670.
    • Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A: Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;1115:659-670.
  • 11
    • 0028874658 scopus 로고
    • Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na + channel blockade and to increases in heart rate: Implications for gene-specific therapy
    • Schwartz PJ, Priori SG, Locati EH, Napolitano C, Cantu F, Towbin JA, Keating MT, Hammoude H, Brown AM, Chen LSK, Colatsky TJ: Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na + channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation 1995;92:3381-3386.
    • (1995) Circulation , vol.92 , pp. 3381-3386
    • Schwartz, P.J.1    Priori, S.G.2    Locati, E.H.3    Napolitano, C.4    Cantu, F.5    Towbin, J.A.6    Keating, M.T.7    Hammoude, H.8    Brown, A.M.9    Chen, L.S.K.10    Colatsky, T.J.11
  • 12
    • 33750049372 scopus 로고    scopus 로고
    • Pharmacologic approach to therapy of Brugada syndrome: Quinidine as an alternative to ICD therapy?; in Antzelevitch C, Brugada P, Brugada J, Brugada R (eds): The Brugada Syndrome: from Bench to Bedside
    • Belhassen B, Viskin S: Pharmacologic approach to therapy of Brugada syndrome: quinidine as an alternative to ICD therapy?; in Antzelevitch C, Brugada P, Brugada J, Brugada R (eds): The Brugada Syndrome: from Bench to Bedside. Oxford, Blackwell Futura, 2004, pp 202-211.
    • (2004) Oxford, Blackwell Futura , pp. 202-211
    • Belhassen, B.1    Viskin, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.